This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: The University of Texas System, Other. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2025
Title: Zeev Estrov: Innovator in Cell Differentiation and Medical Applications
Introduction
Zeev Estrov is a notable inventor based in Houston, TX (US), recognized for his contributions to the field of cell differentiation and medical applications. With a total of 2 patents, Estrov has made significant strides in developing methods that can potentially transform medical treatments.
Latest Patents
Estrov's latest patents include innovative methods for the production of megakaryocytes or platelets from monocytes. This method involves extracting cells from a donor's tissue, isolating CD14 monocytes, and differentiating them into megakaryocytes. The invention aims to provide a solution for patients suffering from platelet deficiencies by administering the differentiated cell types. Another significant patent focuses on methods for transdifferentiating cells, which allows for altering the differentiation state of a cell. This invention demonstrates the potential to convert various cell types into hematopoietic or endothelial cells, utilizing demethylating agents and specific growth factors to guide the differentiation process.
Career Highlights
Throughout his career, Zeev Estrov has worked with esteemed institutions, including the University of Texas System. His work has contributed to advancements in medical applications, particularly in the field of regenerative medicine.
Collaborations
Estrov has collaborated with notable professionals in his field, including Gideon Strassmann and Srdan Verstovsek. These collaborations have further enhanced his research and development efforts.
Conclusion
Zeev Estrov's innovative work in cell differentiation and medical applications showcases his commitment to advancing healthcare solutions. His patents reflect a deep understanding of cellular biology and its potential to address critical medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile